International Survey of Psychosocial Care for Cancer Survivors in Low-/Middle- and High-Income Countries: Current Practices, Barriers, and Facilitators to Care.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
May 2024
Historique:
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 23 5 2024
Statut: ppublish

Résumé

The number of cancer survivors living with and beyond cancer treatment is rising globally. It is fundamental to understand the extent and type of psychosocial care services offered worldwide. We evaluated models of cancer survivorship care, psychosocial care practices in the post-treatment survivorship phase, and barriers/facilitators to delivery of psychosocial care services, including in low- and middle-income countries (LMICs). The International Psycho-Oncology Society (IPOS) Survivorship Special Interest Group led a cross-sectional online survey between March and November 2022. Health care professionals and researchers in psycho-oncology were invited through the IPOS global membership, social media, and snowballing. The survey was administered to individuals but included questions related to practices in their country at a national level. Two hundred eighty-three respondents from 37 countries participated (40% from LMICs), with a median of 12 years of experience (IQR, 6-20) in the psycho-oncology field. Participants reported that the most common elements of routine survivorship care were related to the prevention/management of recurrences/new cancers (74%), physical late effects (59%), and chronic medical conditions (53%), whereas surveillance/management of psychosocial late effects (27%) and psychosocial/supportive care (25%) were least common. Service availability was more commonly reported in high-income countries (HICs) than LMICs related to reproductive health (29% The psychosocial needs of people living with cancer are not adequately available and/or provided in post-treatment survivorship even in HICs, because of barriers at patient, provider, and system levels.

Identifiants

pubmed: 38781550
doi: 10.1200/GO.23.00418
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2300418

Investigateurs

Shiri Altman (S)
Reginald Anang (R)
Chioma Asuzu (C)
Maru Barrera (M)
Karen Basen-Engquist (K)
Pernille Bidstrup (P)
Karine Bilodeau (K)
Isabel Centeno (I)
Stephanie Christodoulidou (S)
Andreja Cirila (A)
Andrea Cohee (A)
László Csaba Dégi (L)
Haryana Dhillon (H)
Saskia Duijts (S)
Tania Estapé (T)
Peter Fisher (P)
Claire Foster (C)
Valentyn Fournier (V)
Isaiah Gitonga (I)
Savita Goswami (S)
Lauren Ha (L)
Tom Hack (T)
Lauren Heathcote (L)
Fuchsia Howard (F)
Nicholas Hulbert-Williams (N)
Paul Jacobsen (P)
Michael Jefford (M)
Angelos Kassianos (A)
Bogda Koczwara (B)
Wendy Lam (W)
Victor Lasebikan (V)
Sophie Lebel (S)
Jesse Lemmen (J)
Monica Leslie (M)
Inbar Levkovich (I)
Jie Li (J)
Beverley Lim Høeg (B)
Xiaohong Liu (X)
Yvonne Luigjes (Y)
Sharon Manne (S)
Dinorah Martinez Tyson (D)
Carolyn Mazariego (C)
Anne Miles (A)
Yurii Mirov (Y)
Louise Mullen (L)
Devi Nandakumar (D)
Ray Nascimento Larissa Nekhlyudo (RN)
Philip Odiyo (P)
Paula Ortolan (P)
Maria Reshetova (M)
Kathy Ruble (K)
Cristina Sade (C)
Joanne Shaw (J)
Christina Signorelli (C)
Anna Singleton (A)
Ben Smith (B)
Škufca Smrdel (Š)
Carolyn Taylor (C)
Luzia Travado (L)
Miyako Tsuchiya (M)
Jane Turner (J)
Surendran Veeraiah (S)
Elizabeth Wells (E)
Lei Xu (L)
Anao Zhang (A)

Auteurs

Christina Signorelli (C)

Discipline of Paediatrics & Child Health, School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, Australia.
Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia.

Beverley Lim Høeg (BL)

Danish Cancer Institute, Copenhagen, Denmark.

Chioma Asuzu (C)

Unit of Psycho-Oncology, Department of Radiation Oncology, College of Medicine, Ibadan, Nigeria.

Isabel Centeno (I)

Breast Cancer Center, Hospital Zambrano Hellion, Monterrey, Mexico.

Tania Estapé (T)

Psychosocial Oncology Department, FEFOC Foundation, Barcelona, Spain.

Peter Fisher (P)

University of Liverpool; Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.

Wendy Lam (W)

School of Public Health, LSK Faculty of Medicine Jockey Club Institute of Cancer Care, The University of Hong Kong, Hong Kong, China.

Inbar Levkovich (I)

Faculty of Graduate Studies, Oranim Academic College of Education, Kiryat Tiv'on, Israel.

Sharon Manne (S)

Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ.

Anne Miles (A)

Department of Psychological Sciences, Birkbeck, University of London, London, United Kingdom.

Louise Mullen (L)

National Cancer Control Programme, Health Services Executive, Kings Inns House, Dublin, Ireland.

Larissa Nekhlyudov (L)

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Cristina Sade (C)

Psychosocial Oncology Department, Instituto Nacional del Cáncer, Santiago, Chile.

Joanne Shaw (J)

School of Psychology, The University of Sydney, Sydney, Australia.

Anna Singleton (A)

Faculty of Medicine and Health, Engagement and Co-design Research Hub, University of Sydney, Sydney, Australia.

Luzia Travado (L)

Champalimaud Clinical and Research Center, Champalimaud Foundation, Lisbon, Portugal.

Miyako Tsuchiya (M)

Division of Healthcare Delivery, Survivorship and Policy Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
Research Institute of Nursing, Musashino University, Tokyo, Japan.

Jesse Lemmen (J)

Pediatric Oncology, Emma's Children Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Jie Li (J)

Center for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
NHC Key Laboratory of Health Economics and Policy Research, Shandong University, Jinan, Shandong, China.

Michael Jefford (M)

Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH